Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -11.50%2.85B | -28.68%668.41M | -15.25%677.93M | -6.88%771.23M | 11.75%735.01M | 8.19%3.22B | 11.54%937.18M | 9.47%799.96M | 11.04%828.2M | -0.67%657.75M |
Cost of revenue | -15.90%862.44M | -25.55%211.09M | -18.32%203.1M | -17.22%237.2M | 2.11%211.05M | 21.56%1.03B | 18.53%283.53M | 12.59%248.66M | 39.28%286.55M | 16.25%206.7M |
Gross profit | -9.44%1.99B | -30.03%457.33M | -13.87%474.83M | -1.41%534.03M | 16.16%523.96M | 2.91%2.2B | 8.76%653.64M | 8.12%551.3M | 0.28%541.65M | -6.89%451.05M |
Operating expense | -13.68%1.71B | -15.82%411.31M | -15.83%408.71M | -16.26%428.4M | -6.71%457.11M | 7.13%1.98B | 6.73%488.59M | 11.31%485.56M | 9.44%511.61M | 1.50%489.96M |
Staff costs | -14.13%853.58M | ---- | ---- | ---- | ---- | 11.59%994.08M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -16.22%484.2M | ---- | ---- | ---- | ---- | 6.43%577.92M | ---- | ---- | ---- | ---- |
-Selling and marketing expense | -15.68%316.63M | ---- | ---- | ---- | ---- | 13.55%375.51M | ---- | ---- | ---- | ---- |
-General and administrative expense | -17.21%167.57M | ---- | ---- | ---- | ---- | -4.67%202.41M | ---- | ---- | ---- | ---- |
Depreciation and amortization | -25.29%68.8M | ---- | ---- | ---- | ---- | -5.16%92.09M | ---- | ---- | ---- | ---- |
-Depreciation | -25.29%68.8M | ---- | ---- | ---- | ---- | -5.16%92.09M | ---- | ---- | ---- | ---- |
Rent and land expenses | -6.30%46.16M | ---- | ---- | ---- | ---- | 9.05%49.26M | ---- | ---- | ---- | ---- |
Other operating expenses | -3.65%252.79M | ---- | ---- | ---- | ---- | -2.13%262.38M | ---- | ---- | ---- | ---- |
Operating profit | 28.25%284.62M | -72.12%46.02M | 0.57%66.12M | 251.56%105.62M | 271.82%66.86M | -23.80%221.93M | 15.27%165.05M | -10.78%65.74M | -58.66%30.04M | -2,395.52%-38.91M |
Net non-operating interest income (expenses) | 21.85%-64.82M | 5.40%-18.53M | 41.80%-11.77M | 24.71%-15.82M | 15.45%-18.7M | 22.32%-82.94M | 51.64%-19.59M | 4.43%-20.23M | 4.95%-21.01M | 3.80%-22.11M |
Non-operating interest income | -86.42%176K | -44.77%169K | -277.78%-560K | -12.58%278K | -19.05%289K | -16.98%1.3M | -19.69%306K | -19.02%315K | -20.30%318K | -8.93%357K |
Non-operating interest expense | -14.03%56.42M | 22.66%18.7M | -29.44%11.21M | -27.00%12.17M | -19.56%14.34M | -27.44%65.63M | -33.76%15.25M | -26.27%15.89M | -25.90%16.67M | -23.78%17.82M |
Total other finance cost | -53.91%8.57M | --0 | --0 | -15.65%3.92M | 0.00%4.65M | 4.07%18.6M | --4.65M | --4.65M | --4.65M | --4.65M |
Net investment income | 0.00%183K | 0 | 0 | 0 | 0.00%183K | 0.00%183K | 0 | 0 | 0 | 0.00%183K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 489.08%32.19M | -49,425.81%-107.47M | -8.91%5.18M | 0 | 134.49M | 116.29%5.47M | -217K | 118.13%5.68M | 0 | 0 |
Less:Other special charges | -2,176.43%-124.41M | 6,930.88%15.26M | ---5.18M | --0 | ---134.49M | -116.29%-5.47M | --217K | ---- | ---- | ---- |
Less:Write off | --92.21M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 527.51%5.31M | 425.02%6.17M | -154.15%-1.36M | 86.40%-1.12M | -50.46%1.63M | -141.36%-1.24M | -93.61%1.18M | 235.65%2.52M | -249.24%-8.22M | 122.35%3.28M |
Income before tax | 79.57%257.48M | -150.42%-73.82M | 8.28%58.16M | 10,755.57%88.69M | 420.50%184.46M | -4.77%143.39M | 20.95%146.41M | 178.02%53.71M | -98.31%817K | -51.39%-57.55M |
Income tax | -187.37%-22.13M | -188.98%-16.23M | 165.91%11.53M | -59.36%-4.69M | -323.58%-12.74M | 18.64%25.33M | 166.25%18.24M | -8.95%4.34M | -3,673.08%-2.94M | -41.96%5.7M |
Net income | 136.84%279.61M | -144.94%-57.6M | -5.57%46.63M | 2,384.17%93.38M | 411.77%197.19M | -8.64%118.06M | 12.23%128.17M | 239.14%49.38M | -92.22%3.76M | -32.24%-63.25M |
Net income continuous operations | 136.84%279.61M | -144.94%-57.6M | -5.56%46.63M | 2,383.51%93.38M | 411.77%197.19M | -8.64%118.06M | 12.23%128.17M | 239.16%49.38M | -92.21%3.76M | -32.24%-63.25M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 136.84%279.61M | -144.94%-57.6M | -5.57%46.63M | 2,384.17%93.38M | 411.77%197.19M | -8.64%118.06M | 12.23%128.17M | 239.14%49.38M | -92.22%3.76M | -32.24%-63.25M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 136.84%279.61M | -144.94%-57.6M | -5.57%46.63M | 2,384.17%93.38M | 411.77%197.19M | -8.64%118.06M | 12.23%128.17M | 239.14%49.38M | -92.22%3.76M | -32.24%-63.25M |
Gross dividend payment | ||||||||||
Basic earnings per share | 125.61%17.53 | -143.13%-3.64 | -13.77%2.88 | 1,889.66%5.77 | 391.16%12.52 | -18.55%7.77 | 0.48%8.44 | 203.64%3.34 | -92.31%0.29 | -15.28%-4.3 |
Diluted earnings per share | 125.90%17.53 | -144.59%-3.64 | -8.42%2.88 | 2,246.38%5.77 | 391.16%12.52 | -16.65%7.76 | -0.69%8.1632 | 196.69%3.145 | -93.18%0.2459 | -15.28%-4.3 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |